Nyvepria and Yellow fever - a phase IV clinical study of FDA data
We study 47 people who take Nyvepria or have Yellow fever. No report of Yellow fever is found in people who take Nyvepria.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.
No report is found.
What is Nyvepria?
Nyvepria has active ingredients of pegfilgrastim-apgf.
What is Yellow Fever?
Yellow fever (acute viral circulation system bleeding disease) is found to be associated with 41 drugs and 29 conditions by eHealthMe.
Do you take Nyvepria and have Yellow fever?Check whether Yellow fever is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Alternative drugs to, pros and cons of Nyvepria:
Yellow fever treatments and more:
- Yellow fever (47 reports)
COVID vaccines that are related to Yellow fever:
- Yellow fever in Moderna COVID Vaccine
- Yellow fever in Pfizer BioNTech Covid Vaccine
- Yellow fever in Johnson and Johnson Covid Vaccine
How severe was Yellow fever and when was it recovered:
Expand to all the drugs that have ingredients of pegfilgrastim-apgf:
All the drugs that are associated with Yellow fever:
All the conditions that are associated with Yellow fever:
How the study uses the data?
The study uses data from the FDA. It is based on pegfilgrastim-apgf (the active ingredients of Nyvepria) and Nyvepria (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Inflectra and Cd4 Lymphocytes Decreased - a second ago
- Azmacort and Nolvadex drug interaction - 2 seconds ago
- Precedex and Dyskinesia - 6 seconds ago
- Doxorubicin Hydrochloride and Agranulocytosis - 13 seconds ago
- Lower Respiratory Tract Infection and Stools - Watery - 15 seconds ago